Clinical Trial Update: Immunogenicity and Safety of a Candidate Tuberculosis (TB) Vaccine Given to Healthy Adults in a TB-endemic Region [Phase 2]

View source ↗

Summary

Phase 2 trial assessing immunogenicity and safety of a TB vaccine candidate in healthy adults in a TB-endemic region; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• GlaxoSmithKline TB vaccine candidate

Snippet

Sponsor: GlaxoSmithKline | Conditions: Tuberculosis (TB), Tuberculosis Vaccines | Phase 2 | Status: COMPLETED